BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 16087828)

  • 1. Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults.
    White RH; Chew HK; Zhou H; Parikh-Patel A; Harris D; Harvey D; Wun T
    Arch Intern Med; 2005 Aug 8-22; 165(15):1782-7. PubMed ID: 16087828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism in ovarian cancer.
    Rodriguez AO; Wun T; Chew H; Zhou H; Harvey D; White RH
    Gynecol Oncol; 2007 Jun; 105(3):784-90. PubMed ID: 17408726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
    Chew HK; Wun T; Harvey DJ; Zhou H; White RH
    J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
    Alcalay A; Wun T; Khatri V; Chew HK; Harvey D; Zhou H; White RH
    J Clin Oncol; 2006 Mar; 24(7):1112-8. PubMed ID: 16505431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism after spinal cord injury: incidence, time course, and associated risk factors in 16,240 adults and children.
    Jones T; Ugalde V; Franks P; Zhou H; White RH
    Arch Phys Med Rehabil; 2005 Dec; 86(12):2240-7. PubMed ID: 16344018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of ovarian cancer subsequent to venous thromboembolism: a nationwide Danish cohort study.
    Tetsche MS; Nørgaard M; Pedersen L; Lash TL; Sørensen HT
    BMC Cancer; 2006 Jul; 6():189. PubMed ID: 16846496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk?
    White RH; Chew H; Wun T
    Thromb Res; 2007; 120 Suppl 2():S29-40. PubMed ID: 18023711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer.
    Sandhu R; Pan CX; Wun T; Harvey D; Zhou H; White RH; Chew HK
    Cancer; 2010 Jun; 116(11):2596-603. PubMed ID: 20336780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between malignant melanoma and noncutaneous malignancies.
    Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
    Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of malignant neoplasms after liver transplantation: a population-based study.
    Aberg F; Pukkala E; Höckerstedt K; Sankila R; Isoniemi H
    Liver Transpl; 2008 Oct; 14(10):1428-36. PubMed ID: 18825704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population-based study of renal cell carcinoma and prostate cancer in the same patients.
    Barocas DA; Rabbani F; Scherr DS; Vaughan ED
    BJU Int; 2006 Jan; 97(1):33-6. PubMed ID: 16336324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of cancer among patients with systemic sclerosis in Korea: results from a single centre.
    Kang KY; Yim HW; Kim IJ; Yoon JU; Ju JH; Kim HY; Park SH
    Scand J Rheumatol; 2009; 38(4):299-303. PubMed ID: 19308805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics.
    Paneesha S; McManus A; Arya R; Scriven N; Farren T; Nokes T; Bacon S; Nieland A; Cooper D; Smith H; O'Shaughnessy D; Rose P;
    Thromb Haemost; 2010 Feb; 103(2):338-43. PubMed ID: 20024496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Occult cancer and pulmonary embolism].
    Debourdeau P; Farge-Bancel D
    Rev Prat; 2007 Apr; 57(7):737-42. PubMed ID: 17626318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of second primary malignancies in women with papillary thyroid cancer.
    Canchola AJ; Horn-Ross PL; Purdie DM
    Am J Epidemiol; 2006 Mar; 163(6):521-7. PubMed ID: 16421240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism.
    White RH; Chan WS; Zhou H; Ginsberg JS
    Thromb Haemost; 2008 Aug; 100(2):246-52. PubMed ID: 18690344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasts in cancer prevalence in Connecticut, Iowa, and Utah.
    Micheli A; Yancik R; Krogh V; Verdecchia A; Sant M; Capocaccia R; Berrino F; Ries L
    Cancer; 2002 Jul; 95(2):430-9. PubMed ID: 12124844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors.
    Wun T; White RH
    Cancer Invest; 2009; 27 Suppl 1():63-74. PubMed ID: 19291526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between venous thromboembolism and perioperative allogeneic transfusion.
    Nilsson KR; Berenholtz SM; Garrett-Mayer E; Dorman T; Klag MJ; Pronovost PJ
    Arch Surg; 2007 Feb; 142(2):126-32; discussion 133. PubMed ID: 17309963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.